Industry News: Volume 1, Issue 1

Tying Health Care Investment to Performance By Brian Klepper and Jeffrey Hogan - GoodRx’s planned initial public offering recently made the news, notable because the company, launched in 2011, has been profitable since 2016. Evidently, it’s become unfashionable for investors to demand proof of performance, so GoodRx’s results shone like a

Industry News: Volume 10, Issue 26

INDUSTRY NEWS Fixing the Biggest Problems in Healthcare   Published on September 27, 2020 By Michael Gorton Teladoc founder, author, keynote speaker, serial entrepreneur. I build world changing companies from ideas. Healthcare is broken. If you believe that statement and you are building a company that should be part of the engine that fixes it, read

Industry News: Volume 10, Issue 25

Johnson & Johnson gears up for 60,000-person COVID-19 vaccine trial, the industry's biggest yet by Eric Sagonowsky - With several COVID-19 vaccines already in phase 3 trials and investigators aiming to enroll tens of thousands of participants, Johnson & Johnson is prepping the largest study yet.  The drugmaker is planning to enroll a whopping

Industry News: Volume 10, Issue 24

Even Asymptomatic People Carry the Coronavirus in High Amounts By Apoorva Mandavilli - Of all the coronavirus’s qualities, perhaps the most surprising has been that seemingly healthy people can spread it to others. This trait has made the virus difficult to contain, and continues to challenge efforts to identify and isolate infected people. To view the

Industry News: Volume 10, Issue 23

Economic analysis of the prevalence and clinical and economic burden of medication error in England By Rachel Ann Elliott, Elizabeth Camacho, Dina Jankovic, Mark J Sculpher, Rita Faria - Medication is the most widely used medical intervention. Harm caused by medication is referred to as an adverse drug event (ADE), and includes medication errors,

Industry News: Volume 10, Issue 22

INDUSTRY NEWS Johnson & Johnson to End Talc-Based Baby Powder Sales in North America By Tiffany Hsu and Roni Caryn Rabin - Johnson & Johnson is discontinuing North American sales of its talc-based baby powder, a product that once defined the company’s wholesome image and that it has defended for decades even as it faced

Industry News: Volume 10, Issue 21

INDUSTRY NEWS Solutions from Around the World: Tackling Loneliness and Social Isolation During COVID-19 By Melinda K. Abrams, Reginald D. Williams II, Roosa Tikkanen, Tanya Shah, and Matt Pantell - As Americans heed the advice of public health and government officials to remain physically distanced from neighbors, friends, and relatives to fight the

Industry News: Volume 10, Issue 20

INDUSTRY NEWS These women entrepreneurs are making medical and healthcare facilities available to allFrom a medical tourism platform, a medical equipment e-marketplace to a portal helping the elderly with doctor’s appointments, these women-led medtech startups are doing their bit to keep you in the pink of health. By Nirandhi Gowthaman – With

Industry News: Volume 10, Issue 19

INDUSTRY NEWS This Coronavirus Is Unlike Anything in Our Lifetime, and We Have to Stop Comparing It to the Flu by Charles Ornstein - As a longtime health care reporter, I see the unfolding coronavirus pandemic as representing everything I’ve read about — from the early days of epidemiology to the staggering toll of the 1918 Spanish Flu pandemic —

Industry News: Volume 10, Issue 18

INDUSTRY NEWS More drugmakers hike U.S. prices as new year begins By Michael Erman –  Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more than 50 drugs on Wednesday, bringing total New Year’s Day drug price increases to more than 250, according to data analyzed by